Brain Tumor Treatments: Canada

Sponsored By

Please Click On The Above Banner For More Details

Search Term: Canada
Please scroll down to see the matching trials.

  (0.9474) RSR-13
  (0.9474) RSR-13
  (0.9474) RSR-13
  (0.9352) Brain Tumor Treatments: Canada
  (0.9017) Brainstem Glioma
  (0.8792) Medulloblastoma
  (0.8658) Pediatric Brain Tumors
  (0.8658) Ependyoma
  (0.8351) Links (webTV version)
  (0.8169) REOLYSIN®
  (0.7967) Chemosensitivity For Oligodendrogliomas
  (0.7967) Online Support Groups
  (0.7967) Links to More Brain Tumor Information
  (0.7967) Online Support Groups
  (0.7742) PCV For Brain Tumors: Abstracts
  (0.7742) Chat Transcript: Dr. Patel
  (0.7742) Oligodendroglioma High Grade
  (0.7742) Virtualtrials Newsletter
  (0.7742) Brain Tumor Centers
  (0.7742) Brain Tumor Organizations
  (0.7742) Brain Tumor Survivor Stories
  (0.7742) Metastatic Brain Tumor
  (0.7742) Metastatic Brain Tumor
  (0.7742) Any Malignant Brain Tumor
  (0.7742) Low Grade Glioma
  (0.7742) Brain Tumor Chat room
  (0.7742) Untitled Document
  (0.7742) Brain Tumor Survivor Stories
  (0.7742) Virtualtrials Survery Results
  (0.7742) Treatments By Geographical Area
  (0.7742) Gliosarcoma
  (0.7742) Brain Tumor Centers

Sorry - There were no pages found that contain that search phrase.


	Showing Treatment 1 to 25 of 42 Next 25	Location	Last Updated

Details	A Pharmacokinetic and Phase 2 Study of Sunitinib Malate in Recurrent Malignant Gliomas	Toronto, Ontario, CANADA	04/21/2009

Details	A Phase II Study of TLN-4601 in Patients With Glioblastoma Multiforme	Toronto, Ontario, CANADA	09/28/2008

Details	NTI 0501: An Open-Labeled, Extended-Use of Human Corticotropin-Releasing Factor (hCRF) (Xerecept) Intended for Patients Who Participate in Dexamethasone-Sparing Studies NTI 0302 or NTI 0303	Edmonton, Alberta, CANADA	03/01/2008

Details	NTI 0501: An Open-Labeled, Extended-Use of Human Corticotropin-Releasing Factor (hCRF) (Xerecept) Intended for Patients Who Participate in Dexamethasone-Sparing Studies NTI 0302 or NTI 0303	Winnipeg, Manitoba, CANADA	03/01/2008

Details	NTI 0501: An Open-Labeled, Extended-Use of Human Corticotropin-Releasing Factor (hCRF) (Xerecept) Intended for Patients Who Participate in Dexamethasone-Sparing Studies NTI 0302 or NTI 0303	Moncton, New Brunswick, CANADA	03/01/2008

Details	NTI 0501: An Open-Labeled, Extended-Use of Human Corticotropin-Releasing Factor (hCRF) (Xerecept) Intended for Patients Who Participate in Dexamethasone-Sparing Studies NTI 0302 or NTI 0303	Ottawa, Ontario, CANADA	03/01/2008

Details	NTI 0501: An Open-Labeled, Extended-Use of Human Corticotropin-Releasing Factor (hCRF) (Xerecept) Intended for Patients Who Participate in Dexamethasone-Sparing Studies NTI 0302 or NTI 0303	Toronto, Ontario, CANADA	03/01/2008

Details	NTI 0501: An Open-Labeled, Extended-Use of Human Corticotropin-Releasing Factor (hCRF) (Xerecept) Intended for Patients Who Participate in Dexamethasone-Sparing Studies NTI 0302 or NTI 0303	Kingston, Ontario, CANADA	03/01/2008

Details	A Randomized Phase III Study of Temozolomide and Short-Course Radiation Versus Short-Course Radiation Alone In The Treatment of Newly Diagnosed Glioblastoma Multiforme in Elderly Patients	Toronto, Ontario, CANADA	08/26/2007

Details	A Phase II Trial to Evaluate the Effect of Low Dose Temozolomide (TMZ) for 2 Weeks (Pre-Surgery) on Brain Tumor O-6-Methylguanine-DNA Methyltransferase (MGMT) Activity in Patients With Gliomas.	Montreal, Canada	08/18/2007

Details	Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor	Hamilton, Canada	08/18/2007

Details	Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study)	, Canada	10/12/2006

Details	Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study)	, Canada	10/12/2006

Details	Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study)	, Canada	10/12/2006

Details	Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study)	, Canada	10/12/2006

Details	Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study)	, Canada	10/12/2006

Details	Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study)	, Canada	10/12/2006

Details	Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma	, Canada	05/30/2006

Details	Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma	, Canada	05/30/2006

Details	Phase 2 Study of Vinblastine in Children With Recurrent or Refractory Low Grade Glioma	Toronto, Ontario, , CANADA	05/21/2006

Details	A Phase I Study of Tomotherapy in Patients With Benign Brain Tumour	Edmonton, Alberta, Canada	05/04/2006

Details	Comparative 2-D Tumor Analysis in Familial Gliomas	Edmonton, Alberta, Canada	05/04/2006

Details	Boron Neutron Capture Therapy Following Surgery in Treating Patients With Glioblastoma Multiforme Removed During Surgery	Toronto, Ontario, Canada	01/08/2006

Details	Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma	, Canada	11/27/2005

Details	Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma	, Canada	11/27/2005

Translate this pageMicrosoftÂ® Translator

Copyright (c) 1993 - 2009 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740

Website Design By